Return Peptide Library
MBX 4291
DLevel 1 evidenceMBX 4291
GLP-1 and incretin receptor agonists
Basic Information
Categories
Monthly GLP-1/GIP dual agonist prodrug
Overview
MBX Biosciences' investigational monthly GLP-1/GIP dual agonist prodrug extends duration of action and significantly reduces dosing frequency.
Efficacy Rating
Study of GLP-1 and GIP
Evidence Level
D-Rank
Evidence Type
No data available
Confidence
No data available
China Regulatory Status
Cosmetic Ingredient Directory
No data available
Food/Supplements
No data available
Medicine
No data available
Similar Peptide Recommendations
ASC35
ASC35
DGLP-1 and incretin receptor agonists
Study of GLP-1 and GIP
VK2735
VK2735
BGLP-1 and incretin receptor agonists
Study of GLP-1 and GIP
ASC30
ASC30
CGLP-1 and incretin receptor agonists
Research, GLP-1, small molecules
Albiglutide
Albiglutide
BGLP-1 and incretin receptor agonists
GLP-1 RA, type 2 diabetes mellitus, discontinued
Disclaimer
The content on this platform is for educational and informational purposes only and does not constitute medical advice, formulation guidance, or a guarantee of regulatory compliance. All efficacy claims are labeled with their evidence level; please consult a professional before making any decisions.